热门搜索:
 
当前位置: 首页 » 信息动态 » 正文

欧盟评估鼠李糖乳杆菌NCIMB 30121作为所有动物饲料添加剂的安全性和有效性

放大字体  缩小字体 时间:2021-11-12 10:51 来源:食品伙伴网 作者: 泽夕    浏览:263  原文:
核心提示:2021年11月8日,据欧盟食品安全局(EFSA)消息,应欧盟委员会要求,欧盟动物饲料添加剂和产品(FEEDAP)研究小组就鼠李糖乳杆菌(Lacticaseibacillus rhamnosus)NCIMB 30121作为所有动物饲料添加剂的安全性和有效性发表科学意见。
   食品伙伴网讯  2021年11月8日,据欧盟食品安全局(EFSA)消息,应欧盟委员会要求,欧盟动物饲料添加剂和产品(FEEDAP)研究小组就鼠李糖乳杆菌(Lacticaseibacillus rhamnosus)NCIMB 30121作为所有动物饲料添加剂的安全性和有效性发表科学意见。
 
  经过评估,专家小组认为,在授权的使用条件下该添加剂对所有动物物种、消费者和环境都是安全的。鼠李糖乳杆菌NCIMB 30121被视为皮肤和呼吸敏化剂,而其对眼睛和皮肤的潜在刺激性没有结论。在更新授权的情况下,无需评估添加剂的功效。部分原文报道如下:
 
  Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of Lacticaseibacillus rhamnosus (formerly Lactobacillus rhamnosus) NCIMB 30121 as a technological additive for all animal species. The additive aims to improve the production of silage and is authorised without a minimum inclusion level. The applicant provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There was no new evidence to lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concluded that the additive remains safe for all animal species, consumers and the environment under the authorised conditions of use. Regarding user safety, the additive should be considered a skin and respiratory sensitiser. No conclusions could be drawn on the eye and skin irritancy potential of the additive. There was no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
 
  本文由食品伙伴网食品资讯中心编辑,有任何疑问,请联系news@foodmate.net。

本文由食品伙伴网编译,供网友参考,食品伙伴网提供欧盟、美国、英国、俄罗斯、日本、韩国、东南亚、西班牙等国家或地区的进出口合规咨询服务,欢迎垂询:0535-2129301,Email:vip@foodmate.net、news@foodmate.net.

日期:2021-11-12
 

声明:

本网转载内容均已注明出处,转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责。
※ 如果有侵权或其他问题,请联系电话:0535-2122172

 
[ 信息动态搜索 ]  [ 告诉好友 ]  [ 打印本文 ]  [ 关闭窗口 ]

 

 
行业相关食品资讯
 
地区相关食品资讯